|3 Months Ended|
Sep. 30, 2018
|Property, Plant and Equipment [Abstract]|
|Property, Plant and Equipment Disclosure [Text Block]||
Note 4 Fixed Assets
The following is a summary of fixed assets and accumulated depreciation:
Depreciation expense was $25,368 and $266,613 for the three months ended September 30, 2018 and 2017, respectively.
During the period ended September 30, 2018, the Company completed sales of laboratory and manufacturing fixed assets for an amount of $187,139. This resulted in the Company recording a gain on sale of fixed assets of $22,852.
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef